Jaydie Lynn King Neuro-oncology Program
Arizona’s only comprehensive program for childhood brain and spinal cord tumors
The Jaydie Lynn King Neuro-oncology Program at Phoenix Children's Hospital is the only comprehensive pediatric program of its kind in Arizona, combining the expertise of subspecialists in the Barrow Neurological Institute at Phoenix Children's and the Center for Cancer and Blood Disorders (CCBD).
Our neuro-oncology program is the only one in Arizona to offer a pediatric neuro-radiology department and access to all supporting subspecialties. We offer family-centered, multidisciplinary, coordinated care to provide hope, healing and the best healthcare for children and their families.
Highly Trained, Experienced Team – All in one place
At Phoenix Children’s Hospital, our experts in oncology, neurosurgery, research, nursing, radiology, psychology, nutrition, rehabilitation, social work and more, make sure our patients get the highest level of care all in one location. Our staff works with specialists at the Hospital to coordinate our patients’ care and minimize stress for the family.
Access to the most Current Therapies Available
Research provides patients with the best, most up-to-date treatments for their illnesses and identifies and evaluates new treatments to help future children. At Phoenix Children's, this translates into cutting edge care and access to the most promising new options. The CCBD is a member of Pediatric Oncology Experimental Therapeutics Investigation Consortium, a group comprised of 10 leading pediatric cancer centers in North America that conduct Phase I clinical trials.
Phoenix Children’s is the only location in Arizona where these advanced treatments are available and the only program in Arizona conducting Phase I clinical trials in addition to Phase II and III. Phase I clinical trials are used in people who have cancer that cannot be treated effectively with standard treatments or for which no standard treatment exists and are limited to only the most advanced and comprehensive centers.
The Hospital is also a member of the Children’s Oncology Group, offering the same Phase II and Phase III trials available at other leading children’s hospitals across the country. Similarly, Barrow at Phoenix Children's are members of other prestigous comprehensive research study groups including:
- POETIC consortium (Boston Children's, Memorial Sloane Kettering, Johns Hopkins, MD Anderson (Florida and Houston), Children's in Denver, Mercy Children's Hospital in Kansas City, Children's Hospital of Hershey, Pennsylvania and the Children's Hospital in Calgary, Canada).
- Head Start Consortium for infants and young children
- Neuroblastoma Medulloblastoma Translational Research Consortium (NMTRC)
- Pediatric Bone Marrow Transplant Consortium (PBMTC)
Collaborations and Affiliations Include:
- Barrow Neurological Institute at St. Joseph's Hospital and Medical Center
- Mayo Hospital
- Translational Genomics Institute (TGEN)
These collaborations increase our available state-of-the-art treatments for children with brain and spine/spinal cord tumors including: endovascular treatment, molecular medicine/precision medicine, gamma knife radiosurgery, stereotactic radiosurgery and soon Proton Beam Therapy, to target cancer and reduce damage to healthy tissue and to organs.